These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Affinity labeling of oxaloacetate decarboxylase by novel dichlorotriazine linked alpha-ketoacids.
    Author: Labrou NE.
    Journal: J Protein Chem; 1999 Oct; 18(7):729-33. PubMed ID: 10691181.
    Abstract:
    The 4-aminophenyloxanilic acid and beta-mercaptopyruvic acid linked to the reactive diclorotriazine ring, were studied as active site-direct affinity labels towards oxaloacetate decarboxylase (EC 4.1.1.3, OXAD). Oxaloacetate decarboxylase when incubated with 4-aminophenyloxanilic-diclorotriazine (APOD) or beta-mercaptopyruvic-diclorotriazine (MPD) at pH 7.0 and 25 degrees C shows a time-dependent and concentration-dependent loss of enzyme activity. The inhibition was irreversible and activity cannot be recovered either by extensive dialysis or gel-filtration chromatography. The enzyme inactivation following the Kitz & Wilson kinetics for time-dependent irreversible inhibition. The observed rate of enzyme inactivation (k(obs)) exhibits a non-linear dependence on APOD or MPD concentration with maximum rate of inactivation (k3) of 0.013 min(-1) and 0.0046 min(-1) and K(D) equal to 20.3 and 156 microM respectively. The inactivation of oxaloacetate decarboxylase by APOD and MPD is competitively inhibited by OXAD substrate and inhibitors, such as oxaloacetate, ADP and oxalic acid whereas Mn+2 enhances the rate of inactivation. The rate of inactivation of OXAD by APOD shows a pH dependence with an inflection point at 6.8, indicating a possible histidine derivatization by the label. These results show that APOD and MPD demonstrate the characteristics of an active-site probe towards the oxaloacetate binding site of oxaloacetate decarboxylase.
    [Abstract] [Full Text] [Related] [New Search]